Insider trading · Q3 2026 · CIK 1821586

MoonLake Immunotherapeutics (MLTX) insider trading.

Name: MoonLake Immunotherapeutics insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at MoonLake Immunotherapeutics reported 8 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $5.3M.

Transactions: 8
Purchases (P): 0
Sales (S): 8
Net shares, P minus S: -263,353
Insiders: 2
Last filed: 2026-07-29

Insiders

Insider	Relationship	Transactions	Buys	Sales
Reich Kristian	Officer · Chief Scientific Officer	5	0	5
Santos da Silva Jorge	Director, Officer · Chief Executive Officer	3	0	3

Transactions

8 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-07-27	Reich Kristian	S (D)	1,100	$20	2,711,198	Form 4
2026-07-22	Reich Kristian	S (D)	2,448	$20	2,712,298	Form 4
2026-07-21	Reich Kristian	S (D)	50,000	$20.02	2,714,746	Form 4
2026-07-20	Reich Kristian	S (D)	43,700	$20.09	2,764,746	Form 4
2026-07-15	Reich Kristian	S (D)	16,105	$20.01	2,808,446	Form 4
2026-07-10	Santos da Silva Jorge	S (D)	68,289	$20.02	2,774,893	Form 4
2026-07-09	Santos da Silva Jorge	S (D)	33,936	$20.01	2,843,182	Form 4
2026-07-01	Santos da Silva Jorge	S (D)	47,775	$20.03	2,877,118	Form 4

Transaction codes in this quarter

S: 8

Get MLTX insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1821586&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · MLTX company page · MoonLake Immunotherapeutics on SEC.gov

Questions

Are insiders buying or selling MoonLake Immunotherapeutics (MLTX)?

In Q3 2026, insiders at MoonLake Immunotherapeutics reported 8 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $5.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these MoonLake Immunotherapeutics insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/mltx.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.